Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Bauer

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell|April 30, 2026
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte functionNicole E Scharping, Xuezhen Ge, Maria Inês Matias, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte functionNicole E Scharping, Xuezhen Ge, Maria Inês Matias, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Clinical Proteomics|January 17, 2026
Plasma proteomic profiling reveals distinct protein signatures associated with hepatocellular carcinoma in chronic hepatitis B infectionSidnooma Véronique Zongo, Michael A Bauer, Lassina Traore, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
<i>BRAF</i> and <i>DIS3</i> Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple MyelomaEileen M Boyle, Cody Ashby, Ruslana G Tytarenko, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell|April 30, 2026
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte functionNicole E Scharping, Xuezhen Ge, Maria Inês Matias, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte functionNicole E Scharping, Xuezhen Ge, Maria Inês Matias, et al.
Blood|November 18, 2018
The genomic landscape of plasma cells in systemic light chain amyloidosisEileen M Boyle, Cody Ashby, Christopher P Wardell, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Clinical Proteomics|January 17, 2026
Plasma proteomic profiling reveals distinct protein signatures associated with hepatocellular carcinoma in chronic hepatitis B infectionSidnooma Véronique Zongo, Michael A Bauer, Lassina Traore, et al.
Blood|August 13, 2016
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myelomaNiels Weinhold, Cody Ashby, Leo Rasche, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
<i>BRAF</i> and <i>DIS3</i> Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple MyelomaEileen M Boyle, Cody Ashby, Ruslana G Tytarenko, et al.
Pageof 4